Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis
Journal of Investigative Dermatology · 2023
DOI: 10.1016/j.jid.2023.01.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2023. Verfasst von David M Dolivo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Myofibroblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Electronic address: seok-hong@northwestern.edu.
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Dolivo, D. M., Rodrigues, A. E., Galiano, R. D., Mustoe, T. A., & Hong, S. J. (2023). Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2023.01.024
Vancouver
Dolivo DM, Rodrigues AE, Galiano RD, Mustoe TA, Hong SJ. Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis. Journal of Investigative Dermatology. 2023. doi:10.1016/j.jid.2023.01.024
BibTeX
@article{Dolivo2023,
author = {Dolivo, David M and Rodrigues, Adrian E and Galiano, Robert D and Mustoe, Thomas A and Hong, Seok Jong},
title = {Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis},
journal = {Journal of Investigative Dermatology},
year = {2023},
doi = {10.1016/j.jid.2023.01.024}
}
EUVIMED